Asia-Pacific Journal of Clinical Oncology · 2021 · 22 citations · 23 references
Life SciencesHematologyImmunologyCancer ImmunologyCellular ImmunologyImmunoregulationCytotoxic T Lymphocyte ResponsesEffector T Cell FunctionHelper T Cell SubsetsRegulatory T CellsT Cell ActivationT Cell BiologyCd4 Positive T CellsCd8 Positive T CellsCytotoxic T Lymphocyte FunctionHematological BiomarkersHost Immune SuppressionImmune Suppression MechanismsPeripheral Blood Lymphocyte AnalysisT-cell Immunoglobulin Domain-containing Protein 3
AIM: To characterize immune suppression in lymphoma, thymocyte selection-associated high mobility group box protein (TOX) expression and co-expression with programmed cell death receptor-1 (PD-1), T cell immunoglobulin mucin-domain-containing-3 (Tim-3), and CD244 in CD3+, CD4+, CD8+, and regulatory T (Treg) cells from patients with lymphomas were analyzed. METHODS: TOX expression and co-expression with PD-1, Tim-3, and CD244 in CD3+, CD4+, Treg, and CD8+ T cells were analyzed by multi-color fluorescent flow cytometry using peripheral blood (PB) from 13 newly diagnosed, untreated lymphoma patients, and 11 healthy individuals. RESULTS: An increased percentage of TOX+ CD3+, CD4+, and CD8+ T cells was found in PB from patients with B cell non-Hodgkin's lymphoma (B-NHL) in comparison with healthy controls. Moreover, TOX+PD-1+ and TOX+Tim-3+ double-positive T cells increased among the CD3+, CD4+, and CD8+T cell populations in the B-NHL group. There was apparent heterogeneity in TOX expression and co-expression with PD-1, Tim-3, and CD244 in CD3+, CD4+, and CD8+ T cells in different lymphoma patients. In addition, the percentage of CD4+CD25+FoxP3+ T cells (Treg) among the CD3+ and CD4+ T cells significantly increased, and the number of TOX+ and TOX+PD-1+ Treg cells also significantly increased in the B-NHL group. CONCLUSIONS: Higher expression of TOX concurrent with PD-1, Tim-3, and CD244 in T cells from patients with B-NHL may contribute to T cell exhaustion and impair their special anti-tumor T cell activity. TOX may be considered a potential target for reversing T cell exhaustion and improving T cell function in hematological malignancies.
23
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Omar Khan, Josephine R. Giles, Sierra J. McDonald et al. · Nature · 2019 · 1.6K citations
TOX is a critical regulator of tumour-specific T cell differentiation
Andrew Scott, Friederike Dündar, Paul Zumbo et al. · Nature · 2019 · 1.1K citations · Full text
Life Sciences, Immunology, Oncology +14